From: Investigating potential drug targets for the treatment of glioblastoma: a Mendelian randomization study
Outcome
Exposure
Methods
nSNP
b
se
pval
GBM
GPX7
MR Egger
1325
0.3844
0.1132
0.0007
Weighted median
0.3077
0.1084
0.0045
Inverse variance weighted
0.1830
0.0633
0.0038
Simple mode
-0.0430
0.3298
0.8965
Weighted mode
0.4933
0.2083
0.0180